share_log

辉瑞将按23亿美元的股权价值收购癌症药物生产商Trillium

Pfizer Inc will acquire Trillium, a maker of cancer drugs, with an equity value of US $2.3 billion

新浪財經 ·  Aug 23, 2021 19:45

Pfizer Inc, maker of COVID-19 vaccineThe company, with an equity value of $2.26 billion, will acquire all the shares it has not yet held in Trillium Therapeutics Inc., a maker of immune cancer drugs.

Pfizer Inc will buy Cambridge, Massachusetts-based Trillium for $18.50 a share, the two companies announced on Monday. This price represents a premium of 118% over its 60-day weighted average price.

Pfizer Inc invested 25 million US dollars in Trillium last September.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment